NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
-15.39%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$115M
AUM Growth
+$115M
(-24%)
Cap. Flow
-$4.83M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
98.09%
Holding
15
New
1
Increased
7
Reduced
2
Closed
2
Top Buys
| 1 |
DERM
Dermira, Inc.
DERM
|
$3.5M |
| 2 |
Dynavax Technologies
DVAX
|
$2.45M |
| 3 |
CMRX
Chimerix, Inc.
CMRX
|
$1.31M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$1.01M |
| 5 |
CALA
Calithera Biosciences, Inc
CALA
|
$889K |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$7.42M |
| 2 |
Esperion Therapeutics
ESPR
|
$4.07M |
| 3 |
RLYP
RELYPSA INC COM
RLYP
|
$2.87M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$902K |
Sector Composition
| 1 | Healthcare | 86.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARAV
1
DELISTED
Aravive, Inc. Common Stock
ARAV
| $23.5M | 20.39% |
2,039,223
| – | – |
|
|
ALDR
2
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $21.8M | 18.89% |
664,783
+7,000
| +1% | +$229K |
|
|
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $18.6M | 16.13% |
1,377,497
| – | – |
|
|
4
Dynavax Technologies
DVAX
$1.19B
| $17.5M | 15.17% |
712,498
+100,000
| +16% | +$2.45M |
|
|
CMRX
5
DELISTED
Chimerix, Inc.
CMRX
| $13.6M | 11.76% |
355,007
+34,399
| +11% | +$1.31M |
|
|
DERM
6
DELISTED
Dermira, Inc.
DERM
| $6.57M | 5.7% |
281,592
+150,002
| +114% | +$3.5M |
|
|
MRNS
7
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.88M | 5.1% |
704,572
+51,078
| +8% | +$426K |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.85M | 2.48% |
114,621
+24,883
| +28% | +$620K |
|
|
CALA
9
DELISTED
Calithera Biosciences, Inc
CALA
| $1.63M | 1.41% |
299,583
+163,693
| +120% | +$889K |
|
|
RLYP
10
DELISTED
RELYPSA INC COM
RLYP
| $1.22M | 1.06% |
65,961
-155,243
| -70% | -$2.87M |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $1.01M | 0.87% |
+23,829
| New | +$1.01M |
|
|
AKAO
12
DELISTED
Achaogen, Inc.
AKAO
| $765K | 0.66% |
132,728
| – | – |
|
|
13
Karyopharm Therapeutics
KPTI
$61.7M
| $431K | 0.37% |
40,977
-85,710
| -68% | -$902K |
|
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-177,230
| Closed | -$7.42M |
|
|
15
Esperion Therapeutics
ESPR
$448M
| – | – |
-49,816
| Closed | -$4.07M |
|